Phosphate Binders in CKD: ‟New Kids on the Block”
DOI:
https://doi.org/10.53778/pjkd31089Palavras-chave:
hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxideResumo
Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.
Downloads
Publicado
Edição
Secção
Licença
Direitos de Autor (c) 2021 Muhammad Umair Afzal, Shafeeq Cheema

Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição-NãoComercial 4.0.
